| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.0B | $9.7B | $9.3B | $8.2B | $7.6B | $5.5B | $4.8B | — |
| Cost of Revenue | $10.8B | $9.5B | $9.0B | $7.9B | $7.4B | $5.4B | $4.8B | — |
| Gross Profit | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.2B | $0.1B | $0.2B | $0.0B | — | — |
| EPS (Basic) | $0.73 | $2.97 | $6.68 | $5.81 | $19.13 | $4.34 | $0.32 | $-0.48 |
| EPS (Diluted) | $0.71 | $2.84 | $6.34 | $5.45 | $17.79 | $4.31 | $0.31 | $-0.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.2B | $1.8B | $1.5B | $1.4B | $1.2B | $0.8B | $0.7B | $0.7B |
| Current Assets | $1.7B | $1.4B | $1.3B | $1.2B | $1.0B | $0.7B | $0.7B | $0.7B |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.0B |
| Total Liabilities | $1.5B | $1.2B | $0.9B | $1.0B | $0.8B | $0.7B | $0.6B | $0.7B |
| Current Liabilities | $1.1B | $0.9B | $0.9B | $0.8B | $0.7B | $0.6B | $0.5B | $0.7B |
| Stockholders' Equity | $0.6B | $0.6B | $0.6B | $0.5B | $0.4B | $0.1B | $0.1B | $0.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $-0.0B | $-0.1B | $-0.1B | $0.0B | $-0.0B | $0.0B |
| Investing Cash Flow | $-0.1B | $-0.1B | $0.0B | $-0.1B | $-0.1B | $0.0B | $-0.0B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $0.0B | $0.0B | $0.1B | $0.2B | $-0.1B | $0.0B | $0.0B |